CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma.
CME information and select publications here.
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma.
CME information and select publications here.
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma.
CME information and select publications here.
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma.
CME information and select publications here.
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma.
CME information and select publications here.
CAR T-Cell Therapy in Non-Hodgkin Lymphoma with Dr Jonathon Cohen
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma.
CME information and select publications here.
Diffuse Large B-Cell Lymphoma (DLBCL): Breaking Down an Aggressive Lymphoma
Jonathon Cohen, MD, MS
When you hear the word “aggressive,” it can feel overwhelming, but in diffuse large B-cell lymphoma (DLBCL), it can also point to something encouraging – a potential cure.
In this episode, we speak with Dr. Jonathon Cohen, of Winship Cancer Institute in Atlanta, GA…
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Guest: Jonathon B. Cohen, MD, MS
As chemotherapy-free approaches for mantle cell lymphoma continue to evolve, important questions remain about how best to incorporate them into clinical practice. Here to help shed light on the key unknowns surrounding patient selection, treatment sequenc…
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Guest: Jonathon B. Cohen, MD, MS
As chemotherapy-free approaches for mantle cell lymphoma continue to evolve, important questions remain about how best to incorporate them into clinical practice. Here to help shed light on the key unknowns surrounding patient selection, treatment sequenc…
Future perspectives in frontline MCL treatment and management: a European and US view
This VJHemOnc podcast episode explores future directions in frontline mantle cell lymphoma (MCL) treatment, focusing on the evolving role of chemotherapy, BTK inhibitors, and autologous stem cell transplantation. Mats Jerkeman, MD, PhD, Lund University, Lund, Sweden, shares a European perspective o…
PODKAST SØGEMOTOR
Du kan bruke vår nettsted til å søke etter3,829,325podkaster og196,586,117episoder etter personer, steder eller emner.
En investering i kunnskap gir best avkastning, så jeg lytter til podkaster.
‐ Benjamin "Llamacorn" Franklin
REDIG
Takk fordi du hjelper med å holde podkast-databasen oppdatert.
